Not finding it? Sign in to also search OpenAlex live.
-
Healthcare Professionals’ Knowledge of Pharmacogenetics and Attitudes Towards Antimicrobial Utilization in Zambia: Implications for a Precision Medicine Approach to Reducing Antimicrobial Resistance2021 Frontiers in Pharmacology article Immunology and Microbiology Antibiotic Use and Resistance Open access
Webrod Mufwambi, Julia Stingl, Collen Mutowembwa Masimirembwa, Justen Manasa, Charles F. B. Nhachi, Nadina Stadler, +8 more
22citations -
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study2025 EClinicalMedicine article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Vasileios Fragoulakis, Jesse Joachim Swen, Margarita-Ioanna Koufaki, Kathrin Blagec, Tanja Blagus, Stefan Böhringer, +35 more
7citations -
The potential of whole genome sequencing in pharmacogenetics: a retrospective health record study in rare disease patients2026 European Journal of Human Genetics article Biochemistry, Genetics and Molecular Biology Genomics and Rare Diseases Open access
Madeline Gorny, Katja Susanne Just, Tim Krüger, Matthias Begemann, Florian Kraft, Thomas Eggermann, +2 more
3citations -
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics2024 The World Journal of Biological Psychiatry article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Xenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot, Andreas Conca, Emmanuelle Corruble, Séverine Crettol, +28 more
38citations -
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 – Pharmacokinetic, pharmacogenetic and clinical aspects2026 Pharmacopsychiatry article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Xenia Marlene Hart, Gerhard Gründer, Stefan Unterecker, Georgios Schoretsanitis, Christoph Hiemke, Ivana Adamovic, +44 more
16citations -
Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study2026 European Journal of Clinical Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Linda Lorenz, Judith Berres, Michael Dieter Denkinger, Dietrich Rothenbacher, Stefanie Braig, Dhayana Dallmeier, +1 more
1citations -
Nutrimetric Validation of Solanidine as Dietary‐Derived CYP2D6 Activity Marker In Vivo2023 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Julian Peter Müller, Jens Andreas Sarömba, Patrick Ziegler, Roman Tremmel, Jens Rengelshausen, Elke Schaeffeler, +4 more
15citations -
Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset2024 Biomedicines article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Justyna Wozniak, Judith Schmitt, Jana Koch, Julia Stingl, Katja Susanne Just
6citations -
Association of Polymorphic Cytochrome P450 Enzyme Pathways with Falls in Multimedicated Older Adults2024 Journal of the American Medical Directors Association article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Katja Susanne Just, Laura M. Pott, Catharina Scholl, Michael Steffens, Michael Dieter Denkinger, Dietrich Rothenbacher, +2 more
4citations -
Impact of steroid hormone levels on estradiol‐mediated regulation of cytochrome P450 2B6 compared to 1B1 in breast cancer cells2024 Basic & Clinical Pharmacology & Toxicology article Biochemistry, Genetics and Molecular Biology Estrogen and related hormone effects Open access
Marco Hoffmann, Julian Peter Müller, Jochen Maurer, A. Folliot, Sabrina Yamoune, Julia Stingl
5citations -
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study2021 Frontiers in Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Katja Susanne Just, Harald Dormann, Mathias Freitag, Marlen Schurig, Miriam Böhme, Michael Steffens, +5 more
20citations -
Evaluation of stabilizing additives to protect activities of cytochrome P450 enzymes for in vitro drug testing and pharmacogenetic studies: Focus on CYP2D62025 Biochimica et Biophysica Acta (BBA) - General Subjects article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism
Sabrina Yamoune, Henner Koch, Daniel Delev, Yvonne G. Weber, Julia Stingl
4citations -
Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status2020 The Pharmacogenomics Journal article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism
Arnim Johannes Gaebler, Katharina Luise Schneider, Julia Stingl, Michael Paulzen
3citations -
Evaluation of a pantoprazole and 4‐desmethylpantoprazole‐sulfate metabolic ratio as a novel CYP2C19 phenotyping method2026 British Journal of Clinical Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Julian Peter Müller, Vladimir N. Belov, Sabrina Yamoune, Bob Miller, Mohammed Hasoumi, Jolanta Tupiec, +4 more
1citations -
Response to “Comment on cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study”2026 European Journal of Clinical Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Linda Lorenz, Judith Berres, Michael Dieter Denkinger, Dietrich Rothenbacher, Stefanie Braig, Dhayana Dallmeier, +1 more
0citations -
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants2021 The World Journal of Biological Psychiatry article Medicine Treatment of Major Depression Open access
Chin B. Eap, Gerhard Gründer, Pierre Baumann, Nicolas Ansermot, Andreas Conca, Emmanuelle Corruble, +24 more
44citations -
Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant ‐ implications for precision dosing in a global perspective2022 British Journal of Clinical Pharmacology article Medicine Treatment of Major Depression Open access
Immaculate Mbongo Langmia, Katja Susanne Just, Sabrina Yamoune, Julian Peter Müller, Julia Stingl
40citations